A high LDH to absolute lymphocyte count ratio in patients with DLBCL predicts for a poor intratumoral immune response and inferior survival

PURPOSE: To test the utility of the circulating Lactate Dehydrogenase (LDH) to absolute lymphocyte count (ALC) ratio (LAR) to predict outcome to conventional first-line chemo-immunotherapy in Diffuse Large B-cell Lymphoma (DLBCL), and investigate its correlation to the tumour immune microenvironment...

Descripción completa

Detalles Bibliográficos
Autores principales: Keane, Colm, Tobin, Joshua, Talaulikar, Dipti, Green, Michael, Crooks, Pauline, Jain, Sanjiv, Gandhi, Maher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955090/
https://www.ncbi.nlm.nih.gov/pubmed/29805761
http://dx.doi.org/10.18632/oncotarget.25306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955090/
https://www.ncbi.nlm.nih.gov/pubmed/29805761
http://dx.doi.org/10.18632/oncotarget.25306

Ejemplares similares